Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.
from NYT > Health https://ift.tt/2WnFQqK
via health&fitness
Aucun commentaire:
Enregistrer un commentaire